Cargando…

Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey

The gut microbiota play a pivotal role in human health. Dysbiosis, alterations in microbiota composition and function, is associated with gastrointestinal disorders, including inflammatory bowel disease (IBD). This international survey aimed to assess physicians’ experiences, perceptions, and practi...

Descripción completa

Detalles Bibliográficos
Autores principales: Parigi, Tommaso Lorenzo, Vieujean, Sophie, Paridaens, Kristine, Dalgaard, Kira, Peyrin-Biroulet, Laurent, Danese, Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672996/
https://www.ncbi.nlm.nih.gov/pubmed/38004817
http://dx.doi.org/10.3390/microorganisms11112806
_version_ 1785149570392522752
author Parigi, Tommaso Lorenzo
Vieujean, Sophie
Paridaens, Kristine
Dalgaard, Kira
Peyrin-Biroulet, Laurent
Danese, Silvio
author_facet Parigi, Tommaso Lorenzo
Vieujean, Sophie
Paridaens, Kristine
Dalgaard, Kira
Peyrin-Biroulet, Laurent
Danese, Silvio
author_sort Parigi, Tommaso Lorenzo
collection PubMed
description The gut microbiota play a pivotal role in human health. Dysbiosis, alterations in microbiota composition and function, is associated with gastrointestinal disorders, including inflammatory bowel disease (IBD). This international survey aimed to assess physicians’ experiences, perceptions, and practices related to microbiome modulation for gastrointestinal conditions, with a focus on IBD. Results from 142 healthcare professionals, predominantly gastroenterologists, confirmed a consensus on the relevance of the gut microbiota in IBD pathogenesis. However, the utilization of microbial composition analysis and probiotics in clinical practice was limited, primarily due to the lack of standardized guidelines and supporting evidence. Physicians held conflicting views on antibiotics, recognizing their potential for inducing remission but also causing flares in IBD. Respondents also had varying opinions on the efficacy of fecal microbiota transplantation (FMT) for different gastrointestinal conditions, with higher confidence in FMT effectiveness for irritable bowel syndrome with diarrhea, pouchitis, and ulcerative colitis. Concerns on FMT included uncertainty about effect duration, administration intervals, and conflicting evidence. Donor selection was believed to be a crucial factor in FMT outcomes. This survey highlights the need for further research and evidence-based guidelines to optimize the use of microbiome-based therapies in clinical practice. As our understanding of the gut microbiome continues to evolve, these insights will contribute to more informed and personalized approaches to managing gastrointestinal disorders.
format Online
Article
Text
id pubmed-10672996
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106729962023-11-19 Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey Parigi, Tommaso Lorenzo Vieujean, Sophie Paridaens, Kristine Dalgaard, Kira Peyrin-Biroulet, Laurent Danese, Silvio Microorganisms Article The gut microbiota play a pivotal role in human health. Dysbiosis, alterations in microbiota composition and function, is associated with gastrointestinal disorders, including inflammatory bowel disease (IBD). This international survey aimed to assess physicians’ experiences, perceptions, and practices related to microbiome modulation for gastrointestinal conditions, with a focus on IBD. Results from 142 healthcare professionals, predominantly gastroenterologists, confirmed a consensus on the relevance of the gut microbiota in IBD pathogenesis. However, the utilization of microbial composition analysis and probiotics in clinical practice was limited, primarily due to the lack of standardized guidelines and supporting evidence. Physicians held conflicting views on antibiotics, recognizing their potential for inducing remission but also causing flares in IBD. Respondents also had varying opinions on the efficacy of fecal microbiota transplantation (FMT) for different gastrointestinal conditions, with higher confidence in FMT effectiveness for irritable bowel syndrome with diarrhea, pouchitis, and ulcerative colitis. Concerns on FMT included uncertainty about effect duration, administration intervals, and conflicting evidence. Donor selection was believed to be a crucial factor in FMT outcomes. This survey highlights the need for further research and evidence-based guidelines to optimize the use of microbiome-based therapies in clinical practice. As our understanding of the gut microbiome continues to evolve, these insights will contribute to more informed and personalized approaches to managing gastrointestinal disorders. MDPI 2023-11-19 /pmc/articles/PMC10672996/ /pubmed/38004817 http://dx.doi.org/10.3390/microorganisms11112806 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Parigi, Tommaso Lorenzo
Vieujean, Sophie
Paridaens, Kristine
Dalgaard, Kira
Peyrin-Biroulet, Laurent
Danese, Silvio
Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey
title Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey
title_full Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey
title_fullStr Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey
title_full_unstemmed Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey
title_short Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey
title_sort efficacy, safety, and concerns on microbiota modulation, antibiotics, probiotics, and fecal microbial transplant for inflammatory bowel disease and other gastrointestinal conditions: results from an international survey
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672996/
https://www.ncbi.nlm.nih.gov/pubmed/38004817
http://dx.doi.org/10.3390/microorganisms11112806
work_keys_str_mv AT parigitommasolorenzo efficacysafetyandconcernsonmicrobiotamodulationantibioticsprobioticsandfecalmicrobialtransplantforinflammatoryboweldiseaseandothergastrointestinalconditionsresultsfromaninternationalsurvey
AT vieujeansophie efficacysafetyandconcernsonmicrobiotamodulationantibioticsprobioticsandfecalmicrobialtransplantforinflammatoryboweldiseaseandothergastrointestinalconditionsresultsfromaninternationalsurvey
AT paridaenskristine efficacysafetyandconcernsonmicrobiotamodulationantibioticsprobioticsandfecalmicrobialtransplantforinflammatoryboweldiseaseandothergastrointestinalconditionsresultsfromaninternationalsurvey
AT dalgaardkira efficacysafetyandconcernsonmicrobiotamodulationantibioticsprobioticsandfecalmicrobialtransplantforinflammatoryboweldiseaseandothergastrointestinalconditionsresultsfromaninternationalsurvey
AT peyrinbirouletlaurent efficacysafetyandconcernsonmicrobiotamodulationantibioticsprobioticsandfecalmicrobialtransplantforinflammatoryboweldiseaseandothergastrointestinalconditionsresultsfromaninternationalsurvey
AT danesesilvio efficacysafetyandconcernsonmicrobiotamodulationantibioticsprobioticsandfecalmicrobialtransplantforinflammatoryboweldiseaseandothergastrointestinalconditionsresultsfromaninternationalsurvey